You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-canonical Notch ligand

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial (RO7247669, Pembrolizumab, Nab-Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
May 2, 2023

Cervical Cancer Trial in Worldwide (Tiragolumab, Atezolizumab)

Active, not recruiting
  • Cervical Cancer
  • Phoenix, Arizona
  • +65 more
Jan 19, 2023

NSCLC Trial (pembrolizumab, carboplatin, paclitaxel)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • pembrolizumab
  • +3 more
  • (no location specified)
Aug 18, 2022

NSCLC Trial (Pembrolizumab, Docetaxel)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 18, 2022

Advanced Solid Tumors Trial in Shanghai (HRXG-K-1939, Adebrelimab)

Not yet recruiting
  • Advanced Solid Tumors
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 4, 2023

Non Small Cell Lung Cancer Trial in Spain (Pembrolizumab)

Recruiting
  • Non Small Cell Lung Cancer
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +11 more
May 4, 2022

Malignant Tumor Trial in Beijing (99mTc-CNDG SPECT/CT)

Recruiting
  • Malignant Tumor
  • 99mTc-CNDG SPECT/CT
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 3, 2023

NSCLC Trial in Worldwide (Sacituzumab Govitecan-hziy (SG), Docetaxel)

Recruiting
  • Non-Small Cell Lung Cancer
  • Anchorage, Alaska
  • +104 more
Jul 20, 2022

Salivary Gland Cancer, Salivary Duct Carcinoma Trial in Nijmegen (68Ga-PSMA-PET/CT, 18FDG-PET/CT)

Recruiting
  • Salivary Gland Cancer
  • Salivary Duct Carcinoma
  • 68Ga-PSMA-PET/CT
  • 18FDG-PET/CT
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Aug 15, 2022

Lung Cancer Trial in Worldwide (Pembrolizumab, Epacadostat, Placebo)

Completed
Has Results
  • Lung Cancer
  • Anaheim, California
  • +100 more
Jan 19, 2022

NSCLC, Squamous Non-small-cell Lung Cancer, Squamous Non-Small Cell Tumor of Lung Trial in United States (sapanisertib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Davis, California
  • +13 more
Nov 7, 2022

Airway Management Trial in Brno (Laryngeal mask insertion)

Recruiting
  • Airway Management
  • Laryngeal mask insertion
  • Brno, South Moravian Region, Czechia
    Brno University Hospital
Jan 31, 2022

Fibrolamellar Hepatocellular Carcinoma Trial in Tuebingen (Fusion-VAC-XS15)

Not yet recruiting
  • Fibrolamellar Hepatocellular Carcinoma
  • Tuebingen, Baden-Würtemberg, Germany
    University Hospital Tuebingen
Jun 29, 2023

Metastatic Castration-resistant Prostate Cancer Trial (Pembrolizumab, Enzalutamide)

Completed
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Aug 16, 2022

Non Small Cell Lung Cancer Metastatic Trial in Worldwide (TG4010, Chemotherapy, Nivolumab)

Completed
Has Results
  • Non Small Cell Lung Cancer Metastatic
  • TG4010
  • +2 more
  • Charlotte, North Carolina
  • +8 more
Dec 22, 2021

Hypovitaminosis D, Osteoporosis, Postmenopausal, Menopause Trial in Mexico City (Cholecalciferol)

Completed
  • Hypovitaminosis D
  • +2 more
  • Mexico City, Gustavo A. Madero, Mexico
    Patricia Loranca-Moreno
Jan 24, 2023

Prostate Cancer Trial in Beijing (Al18F-PSMA-617, 68Ga-PSMA-617)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 2, 2023

SARS CoV-2 Post-Acute Sequelae Trial in Birmingham (DPA-714 PET/MRI)

Not yet recruiting
  • SARS CoV-2 Post-Acute Sequelae
  • DPA-714 PET/MRI
  • Birmingham, Alabama
    UAB
Dec 16, 2022

HIV Trial in Liège (Treatment simplification (dolutegravir lamivudine))

Active, not recruiting
  • HIV Infections
  • Treatment simplification (dolutegravir lamivudine)
  • Liège, Belgium
    Liège university hospital
Apr 27, 2022

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

NSCLC Trial in Saint Petersburg, Cremona, Vilnius (REGN2810/ipi, REGN2810/chemo/ipi, Pembrolizumab)

Terminated
Has Results
  • Non-small Cell Lung Cancer
  • Saint Petersburg, Florida
  • +2 more
Oct 22, 2022

Chronic Shoulder Pain Trial in Kayseri (US guided, SSNB with 1ml methylprednisolone acetate (1ml / 40mg) and 5 ml 0.5%

Recruiting
  • Chronic Shoulder Pain
  • US guided, SSNB with 1ml methylprednisolone acetate (1ml / 40mg) and 5 ml 0.5% bupivacaine
  • Kayseri, Turkey
    Erciyes University Faculty of Medicine Hospital
Jun 16, 2021

Triple Negative Breast Cancer, PD-L1 Positive Trial in Puerto Rico, United States (Sacituzumab Govitecan-hziy, Pembrolizumab,

Recruiting
  • Triple Negative Breast Cancer
  • PD-L1 Positive
  • Sacituzumab Govitecan-hziy
  • +5 more
  • Anchorage, Alaska
  • +245 more
Jan 12, 2023

Unresectable Head and Neck Squamous Cell Carcinoma, Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in Worldwide

Recruiting
  • Unresectable Head and Neck Squamous Cell Carcinoma
  • +2 more
  • BNT113
  • Pembrolizumab
  • Los Angeles, California
  • +79 more
Jan 9, 2023

Metastatic Non Small Cell Lung Cancer Trial in Worldwide (Pembrolizumab/Vibostolimab coformuation, Docetaxel, Placebo)

Active, not recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Pembrolizumab/Vibostolimab coformuation
  • +2 more
  • Los Angeles, California
  • +94 more
Jan 4, 2023